BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 29494669)

  • 1. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
    Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
    PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
    Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
    Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma.
    Park JK; Lee YJ; Lee JK; Lee KT; Choi YL; Lee KH
    Oncotarget; 2017 Jan; 8(2):3519-3527. PubMed ID: 27974679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.
    Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A
    Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
    Xu Y; Hu D; Zhu Q; Sun Y
    Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
    Reicher S; Boyar FZ; Albitar M; Sulcova V; Agersborg S; Nga V; Zhou Y; Li G; Venegas R; French SW; Chung DS; Stabile BE; Eysselein VE; Anguiano A
    Pancreas; 2011 Oct; 40(7):1057-62. PubMed ID: 21705950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer.
    Bournet B; Selves J; Grand D; Danjoux M; Hanoun N; Cordelier P; Buscail L
    J Clin Gastroenterol; 2015 Jan; 49(1):50-6. PubMed ID: 24798941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS Mutation Testing on Endoscopic Ultrasound-Guided Fine-Needle Aspiration Samples Improves the Diagnostic Accuracy of Pancreatic Cancer.
    Yeung MCF; Shek TWH
    Pancreas; 2022 Nov-Dec 01; 51(10):1365-1371. PubMed ID: 37099780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and diagnostic value of next-generation sequencing analysis of residual liquid-based cytology specimens of pancreatic masses.
    Sekita-Hatakeyama Y; Fujii T; Nishikawa T; Mitoro A; Sawai M; Itami H; Morita K; Uchiyama T; Takeda M; Sho M; Yoshiji H; Hatakeyama K; Ohbayashi C
    Cancer Cytopathol; 2022 Mar; 130(3):202-214. PubMed ID: 34665935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma.
    Suzuki R; Irie H; Takagi T; Sugimoto M; Konno N; Sato Y; Watanabe K; Nakamura J; Marubashi S; Hikichi T; Ohira H
    BMC Cancer; 2018 Oct; 18(1):974. PubMed ID: 30314433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation.
    Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S
    Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [KRAS mutation assay on EUS-FNA specimens from pacients with pancreatic mass].
    Bunganič B; Hálková T; Benešová L; Belšánová B; Laclav M; Hrůzová M; Traboulsi E; Frič P; Suchánek Š; Minárik M; Zavoral M
    Cas Lek Cesk; 2016; 155(1):48-51. PubMed ID: 26898792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA.
    Cazacu IM; Semaan A; Stephens B; Swartzlander DB; Guerrero PA; Singh BS; Lungulescu CV; Danciulescu MM; Cherciu Harbiyeli IF; Streata I; Popescu C; Saftoiu A; Roy-Chowdhuri S; Maitra A; Bhutani MS
    Gastrointest Endosc; 2021 May; 93(5):1142-1151.e2. PubMed ID: 33058885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
    Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
    World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
    Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
    Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic efficacy of cell block immunohistochemistry, smear cytology, and liquid-based cytology in endoscopic ultrasound-guided fine-needle aspiration of pancreatic lesions: a single-institution experience.
    Qin SY; Zhou Y; Li P; Jiang HX
    PLoS One; 2014; 9(9):e108762. PubMed ID: 25259861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras gene mutation analysis to diagnosis pancreatic adenocarcinoma from endoscopic ultrasound-guided tissue acquisition; a systematic review and meta-analysis.
    Tamura T; Ashida R; Wan K; Shimokawa T; Kitano M
    Pancreatology; 2024 Feb; 24(1):78-87. PubMed ID: 38042675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic efficacy of liquid-based cytology for solid pancreatic lesion samples obtained with endoscopic ultrasound-guided fine-needle aspiration: Propensity score-matched analysis.
    Hashimoto S; Taguchi H; Higashi M; Hatanaka K; Fujita T; Iwaya H; Nakazawa J; Arima S; Iwashita Y; Sasaki F; Nasu Y; Kanmura S; Ido A
    Dig Endosc; 2017 Jul; 29(5):608-616. PubMed ID: 28160342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.